• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医护人员接种灭活 SARS-CoV-2 疫苗(科兴疫苗)的安全性和不良反应。

Safety and Adverse Effects of Inactive SARS-Cov-2 Vaccine (CoronaVac) in Health Care Professionals.

机构信息

Department of Family Medicine, Tekirdag Namik Kemal University, Tekirdag, Turkey.

Department of Surgical Nursing, Tekirdag Namik Kemal University, School of Health, Tekirdag, Turkey.

出版信息

J Pak Med Assoc. 2022 Sep;72(9):1792-1796. doi: 10.47391/JPMA.4844.

DOI:10.47391/JPMA.4844
PMID:36280978
Abstract

OBJECTIVE

To assess adverse effects post-vaccination in healthcare professionals in the first vaccinated group against coronavirus disease-2019.

METHODS

The retrospective study was conducted at the Indus Hospital, Badin, The prospective study was conducted at the vaccination unit of a university hospital in Tekirdag, Turkey, from January to February 2021, and comprised healthcare professionals who came for receiving the second dose of the coronavirus disease-2019 inactivated severe acute respiratory syndrome coronavirus 2 vaccine 28 days after the first dose. Data was analysed using SPSS 18.

RESULTS

Of the 1088 subjects, 714(65.6%) were female with mean age 29.85±9.2 years and 374(34.4%) were male with mean age 29.57±9.85 years. Overall, local pain in the vaccinated area 495(45.5%), fatigue 266(24.4%), headache 261(23.9%) and muscle pain 197(18.1%) were very common adverse effects.

CONCLUSIONS

Inactivated severe acute respiratory syndrome coronavirus 2 vaccine was found to be safe.

摘要

目的

评估首组接种 2019 年冠状病毒病疫苗的医护人员的接种后不良反应。

方法

本回顾性研究于 2021 年 1 月至 2 月在巴基斯坦信德省巴丁的因迪斯医院进行,前瞻性研究在土耳其特克迪尔达格的一所大学医院的接种单位进行,纳入对象为首剂接种 28 天后前来接种 2019 年冠状病毒病灭活严重急性呼吸综合征冠状病毒 2 疫苗第二剂的医护人员。数据使用 SPSS 18 进行分析。

结果

1088 名受试者中,714 名(65.6%)为女性,平均年龄 29.85±9.2 岁,374 名(34.4%)为男性,平均年龄 29.57±9.85 岁。总体而言,接种部位局部疼痛 495 例(45.5%)、疲劳 266 例(24.4%)、头痛 261 例(23.9%)和肌肉疼痛 197 例(18.1%)是非常常见的不良反应。

结论

严重急性呼吸综合征冠状病毒 2 灭活疫苗被认为是安全的。

相似文献

1
Safety and Adverse Effects of Inactive SARS-Cov-2 Vaccine (CoronaVac) in Health Care Professionals.医护人员接种灭活 SARS-CoV-2 疫苗(科兴疫苗)的安全性和不良反应。
J Pak Med Assoc. 2022 Sep;72(9):1792-1796. doi: 10.47391/JPMA.4844.
2
Safety and immunogenicity of inactivated COVID-19 vaccine in health care workers.医护人员中灭活 COVID-19 疫苗的安全性和免疫原性。
J Med Virol. 2022 Apr;94(4):1442-1449. doi: 10.1002/jmv.27458. Epub 2021 Nov 24.
3
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.一项评估 SARS-CoV-2 疫苗(灭活,Vero 细胞)有效性和安全性的随机、双盲、安慰剂对照 III 期临床试验:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1.
4
Safety of an inactivated SARS-CoV-2 vaccine among healthcare workers in China.中国医护人员中灭活 SARS-CoV-2 疫苗的安全性。
Expert Rev Vaccines. 2021 Jul;20(7):891-898. doi: 10.1080/14760584.2021.1925112. Epub 2021 May 13.
5
[Factors Affecting Side Effects, Seroconversion Rates and Antibody Response After Inactivated SARS-CoV-2 Vaccination in Healthcare Workers].[医护人员接种新型冠状病毒灭活疫苗后副作用、血清转化率及抗体反应的影响因素]
Mikrobiyol Bul. 2021 Oct;55(4):519-538. doi: 10.5578/mb.20219705.
6
[The Second Shot of CoronaVac Vaccine May Cause Reduction of Antibody Levels in People who Previously had COVID-19].科兴新冠疫苗第二针可能导致曾感染新冠病毒者抗体水平下降
Mikrobiyol Bul. 2022 Jan;56(1):139-142. doi: 10.5578/mb.20229913.
7
Safety of Inactivated and mRNA COVID-19 Vaccination Among Patients Treated for Hypothyroidism: A Population-Based Cohort Study.甲状腺功能减退症患者接种灭活新冠疫苗和 mRNA 新冠疫苗的安全性:一项基于人群的队列研究。
Thyroid. 2022 May;32(5):505-514. doi: 10.1089/thy.2021.0684. Epub 2022 Apr 7.
8
The impact of previous SARS-CoV-2 infection on post-vaccine adverse events in individuals vaccinated with TURKOVAC or CoronaVac -inactivated COVID-19 vaccines.既往 SARS-CoV-2 感染对 TURKOVAC 或科兴新冠病毒灭活疫苗接种者疫苗后不良事件的影响。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2346388. doi: 10.1080/21645515.2024.2346388. Epub 2024 Jun 26.
9
Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): A multicenter study.非酒精性脂肪性肝病患者 COVID-19 疫苗接种的安全性和免疫原性(CHESS2101):一项多中心研究。
J Hepatol. 2021 Aug;75(2):439-441. doi: 10.1016/j.jhep.2021.04.026. Epub 2021 Apr 24.
10
Immunogenicity after two doses of inactivated virus vaccine in healthcare workers with and without previous COVID-19 infection: Prospective observational study.医护人员接种两剂灭活病毒疫苗后的免疫原性:有和无既往 COVID-19 感染的前瞻性观察研究。
J Med Virol. 2022 Jan;94(1):279-286. doi: 10.1002/jmv.27316. Epub 2021 Sep 10.

引用本文的文献

1
Safety and immunogenicity of CoronaVac in healthy adults: A prospective observational multicenter real-world study in Henan Province, China.CoronaVac 在健康成年人中的安全性和免疫原性:中国河南省前瞻性观察性多中心真实世界研究。
Virulence. 2024 Dec;15(1):2310450. doi: 10.1080/21505594.2024.2310450. Epub 2024 Feb 7.